BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 10962926)

  • 21. Velocardiofacial syndrome or DiGeorge's anomaly.
    Buchanan LM; Hargreaves A; Warwick MM
    Lancet; 2001 Aug; 358(9279):420. PubMed ID: 11503624
    [No Abstract]   [Full Text] [Related]  

  • 22. CATCH 22.
    Hall JG
    J Med Genet; 1993 Oct; 30(10):801-2. PubMed ID: 8230153
    [No Abstract]   [Full Text] [Related]  

  • 23. 22q11 deletion in DGS/VCFS monozygotic twins with discordant phenotypes.
    Vincent MC; Heitz F; Tricoire J; Bourrouillou G; Kuhlein E; Rolland M; Calvas P
    Genet Couns; 1999; 10(1):43-9. PubMed ID: 10191428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.
    Sullivan KE
    Immunol Allergy Clin North Am; 2008 May; 28(2):353-66. PubMed ID: 18424337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The phenotypic spectrum of the 10p deletion syndrome versus the classical DiGeorge syndrome.
    Van Esch H; Groenen P; Fryns JP; Van de Ven W; Devriendt K
    Genet Couns; 1999; 10(1):59-65. PubMed ID: 10191430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Research on behavioral phenotypes: velocardiofacial syndrome (deletion 22q11.2).
    Wang PP; Woodin MF; Kreps-Falk R; Moss EM
    Dev Med Child Neurol; 2000 Jun; 42(6):422-7. PubMed ID: 10875531
    [No Abstract]   [Full Text] [Related]  

  • 27. Selected papers and abstracts of the Velo-Cardio-Facial Syndrome (del22q11) Meeting. Strasbourg, September 5-6, 1998.
    Genet Couns; 1999; 10(1):1-115. PubMed ID: 10438198
    [No Abstract]   [Full Text] [Related]  

  • 28. The 22q11.2 deletion syndrome: more answers but more questions.
    Fernhoff PM
    J Pediatr; 2000 Aug; 137(2):145-7. PubMed ID: 10931401
    [No Abstract]   [Full Text] [Related]  

  • 29. Concurrent microdeletion and duplication of 22q11.2.
    Blennow E; Lagerstedt K; Malmgren H; Sahlén S; Schoumans J; Anderlid B
    Clin Genet; 2008 Jul; 74(1):61-7. PubMed ID: 18445048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease.
    Staple L; Andrews T; McDonald-McGinn D; Zackai E; Sullivan KE
    Pediatr Allergy Immunol; 2005 May; 16(3):226-30. PubMed ID: 15853951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective analysis of feeding and speech disorders in 50 patients with velo-cardio-facial syndrome.
    Rommel N; Vantrappen G; Swillen A; Devriendt K; Feenstra L; Fryns JP
    Genet Couns; 1999; 10(1):71-8. PubMed ID: 10191432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis.
    Driscoll DA; Salvin J; Sellinger B; Budarf ML; McDonald-McGinn DM; Zackai EH; Emanuel BS
    J Med Genet; 1993 Oct; 30(10):813-7. PubMed ID: 8230155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered replication timing of the HIRA/Tuple1 locus in the DiGeorge and Velocardiofacial syndromes.
    D'Antoni S; Mattina T; Di Mare P; Federico C; Motta S; Saccone S
    Gene; 2004 May; 333():111-9. PubMed ID: 15177686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of three diagnostic approaches (FISH, STRs and MLPA) in 30 patients with 22q11.2 deletion syndrome.
    Fernández L; Lapunzina P; Arjona D; López Pajares I; García-Guereta L; Elorza D; Burgueros M; De Torres ML; Mori MA; Palomares M; García-Alix A; Delicado A
    Clin Genet; 2005 Oct; 68(4):373-8. PubMed ID: 16143025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial deletion of 22q11.2.
    Rodríguez Criado G; Gruesomontero J; Delicado Navarro A
    Genet Couns; 1999; 10(3):325-7. PubMed ID: 10546107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Velopharyngoplasty for noncleft velopharyngeal insufficiency: results in relation to 22q11 microdeletion.
    Rouillon I; Leboulanger N; Roger G; Maulet M; Marlin S; Loundon N; Portnoï MF; Denoyelle F; Garabédian EN
    Arch Otolaryngol Head Neck Surg; 2009 Jul; 135(7):652-6. PubMed ID: 19620585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of 22q11 region deletions in patients with velopharyngeal insufficiency.
    Zori RT; Boyar FZ; Williams WN; Gray BA; Bent-Williams A; Stalker HJ; Rimer LA; Nackashi JA; Driscoll DJ; Rasmussen SA; Dixon-Wood V; Williams CA
    Am J Med Genet; 1998 Apr; 77(1):8-11. PubMed ID: 9557885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Avoiding perils and pitfalls in velocardiofacial syndrome: an otolaryngologist's perspective.
    Cable BB; Mair EA
    Ear Nose Throat J; 2003 Jan; 82(1):56-60. PubMed ID: 12610907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited t(9;22) as the cause of DiGeorge syndrome: a case report.
    Shuib S; Abdul Latif Z; Abidin NZ; Akmal SN; Zakaria Z
    Malays J Pathol; 2009 Dec; 31(2):133-6. PubMed ID: 20514857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on clinical features and fluorescence in situ hybridization detections of 22q11 microdeletion syndrome].
    Qin YF; Yang JB; Xie CH; Shao J; Zhao ZY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):284-7. PubMed ID: 17557238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.